11 records totalling $1,457,027.00 CAD, from official Government of Canada open data.
| National Research Council Canada | $1,457,027 | 11 records |
An new anti-inflammatory compound will be advanced into formulation optimization, chemical scale-up and efficacy profiling studies in ocular inflammatory disorders.
This project involves preclinical studies that will be performed to support development of the firm's lead molecule, an inhibitor of leukotriene production, as a potential novel therapy for inflammato...
The project will involve conducting proof of concept in vivo efficacy and isolation of an optically pure lead compound to support development of a novel therapeutic as a potential treatment for certai...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.